Literature DB >> 22266148

Novel and recurrent COL7A1 mutation in a Polish population.

Katarzyna Wertheim-Tysarowska1, Agnieszka Sobczyńska-Tomaszewska, Cezary Kowalewski, Anna Kutkowska-Kaźmierczak, Katarzyna Woźniak, Katarzyna Niepokój, Alfred Klausegger, Joanna Sypniewska-Jutkiewicz, Anna Stępień, Jerzy Bal.   

Abstract

Dystrophic Epidermolysis Bullosa (DEB) is a rare bullous genodermatosis caused by mutations in COL7A1, which encodes collagen type VII, the main component of anchoring fibrilis. DEB is inherited in an autosomal recessive and dominant manner, depending on the mutation type and localization. The aim of this study was to update the spectrum and frequency of COL7A1 mutations in a cohort of 42 Polish DEB patients. Using direct sequencing strategy we identified 25 different mutations, which gave us a detection rate of about 88%. In total, thirteen novel variants were identified, including three de novo mutations (p.G2680S, p.G2043R and p.Gly2064_Arg2069del). The panel of recessively inherited DEB causing recurrent mutations comprise of five variants: c.425A>G, c.682+1G>A, p.R2069C, p.W796X and, unreported before, c.7154delC, which accounts for about 59% of all mutated alleles in this group. In the dominant type of DEB, only p.G2043R was found to be recurrent and it was identified in 50% patients. Our results give further insight into the pathogenesis and epidemiology of DEB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266148     DOI: 10.1684/ejd.2011.1583

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

1.  A novel deletion and two recurrent substitutions on type VII collagen gene in seven Iranian patients with epidermolysis bullosa.

Authors:  Armita Kakavand Hamidi; Mohammad Moghaddam; Nasim Hatamnejadian; Ahmad Ebrahimi
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

2.  Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen.

Authors:  Katarzyna Osipowicz; Piotr Wychowanski; Pawel Nieckula; Sara Shamsa; Katarzyna Wertheim-Tysarowska; Katarzyna Wozniak; Cezary Kowalewski
Journal:  Postepy Dermatol Alergol       Date:  2020-07-14       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.